Page last updated: 2024-08-25

brusatol and Laryngeal Neoplasms

brusatol has been researched along with Laryngeal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bai, Y; Gao, J; Hou, J; Wang, J; Zhou, J	1

Other Studies

1 other study(ies) available for brusatol and Laryngeal Neoplasms

Article	Year
Brusatol inhibits laryngeal cancer cell proliferation and metastasis via abrogating JAK2/STAT3 signaling mediated epithelial-mesenchymal transition. Life sciences, 2021, Nov-01, Volume: 284 Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Laryngeal Neoplasms; Male; Mice, Inbred BALB C; Neoplasm Metastasis; Phosphorylation; Quassins; RNA, Messenger; S Phase; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays	2021

Article

Year

Brusatol inhibits laryngeal cancer cell proliferation and metastasis via abrogating JAK2/STAT3 signaling mediated epithelial-mesenchymal transition.

Life sciences, 2021, Nov-01, Volume: 284

Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Laryngeal Neoplasms; Male; Mice, Inbred BALB C; Neoplasm Metastasis; Phosphorylation; Quassins; RNA, Messenger; S Phase; Signal Transduction; STAT3 Transcription Factor; Xenograft Model Antitumor Assays

2021